We have shown recently that high-intensity focused ultrasound (HIFU) can be used to achieve hemostasis in two laboratory models of hemorrhage. First, we demonstrated that in rabbits we could stop both profuse and minor oozing bleeds from liver incisions with HIFU application. 1 Second, we showed that in pigs we could stop moderate to profuse bleeding from major blood vessels that had been surgically exposed and punctured. 2 In the current study, we report on a further step in the development of acoustic hemostasis devices: mechanical scanning HIFU for the hemostasis of large incisions in blood vessels.
focus after a few seconds of HIFU application. These high temperatures can result in coagulation necrosis of tissue and the fusion of blood vessel walls. 2 HIFU may be useful in numerous applications, including vascular surgery procedures such as vascular anastomoses, the treatment of iatrogenic vascular injuries, and the treatment of vascular injuries resulting from blunt or penetrating trauma.
MATERIALS AND METHODS
Four pigs (two male and two female; age range, 3 to 5 months; weight range, 30 to 100 kg) were used for the experiments. The procedures were performed according to the guidelines of the United States National Institute of Health for the use of laboratory animals. The pigs underwent initial sedation in the animal housing facility with an intramuscular injection of a mixture of acepromazine maleate and ketamine hydrochloride at a dose of 1 mg/kg and 22 mg/kg of body weight, respectively. After transport to the laboratory, the animals underwent anesthesia with a ketamine hydrochloride/xylazine hydrochloride mixture, 8:1 ratio, at a dose of 3.5 to 4 mL with dose to effect. The animals were intubated and kept under anesthesia with halothane, with assisted positive pressure ventilation. The heart rate and the oxygen saturation level were monitored throughout the experiment.
The blood vessels of interest were exposed (Table I) . A longitudinal incision, 2 to 8 mm in length, was made with a no. 11 scalpel. Moderate to profuse bleeding occurred with this transmural injury. The blood loss from the injury varied on the basis of the incision length and the hemodynamic condition of the animal. Bleeding rates as high as 40 mL in 10 seconds were measured by collecting the blood in a beaker. HIFU treatment was applied within 5 seconds of the incision by placing the tip of the cone (focal spot of the HIFU beam, described below) on the bleeding site (Fig 1) . The treatment protocol consisted of HIFU application for 2 to 10 seconds, followed by a visual observation to assess whether the bleeding had stopped. Additional HIFU treatments of a similar duration were applied if the bleeding had not stopped. If 2 to 3 repeated additional treatments did not result in hemostasis, no more treatment was applied and the result was recorded as incomplete hemostasis. All treatments were performed with mechanical scanning of the HIFU probe. After the completion of the treatment, the patency of the vessel was determined by palpation. Two time points-major and complete hemostasis-were recorded for each treatment. Major hemostasis was defined as the reduction of the major bleeding to a slow oozing (approximately 1 mL/min), and complete hemostasis was defined as the complete arrest of bleeding. Statistical analysis of the major and complete hemostasis times was performed with t tests, assuming unequal variance of the populations.
The HIFU transducer characteristics are described elsewhere. 2 Briefly, the transducer for the treatment (Sonic Concepts, Woodinville, Wash) was spherically concave, with a focal length of 55 mm, an aperture diameter of 35 mm, and a resonant frequency of 3.5 MHz. The half maximum beam width and length in the focal region were 1 and 9 mm, respectively. The driving electronics were composed of an HP 33120A function generator (Hewlett Packard, Palo Alto, Calif) whose output was connected to an ENI AP400B power amplifier (ENI, Rochester, NY). A custom-made electrical matching network was connected between the amplifier and the transducer. The HIFU transducer was equipped with a conical housing, which was made of clear plastic, with a height of JOURNAL OF VASCULAR SURGERY Schematic drawing of high-intensity focused ultrasound application to a bleeding vessel. Tip of conical housing was placed on incision site, and mechanically-scanned high-intensity focused ultrasound was applied. 50 mm and a tip opening of 3.1 mm in diameter. The conical housing was filled with degassed water for ultrasonic coupling from the transducer to the tissue. The tip was covered with a polyurethane membrane. The cone geometry allowed the center of the focal spot of the transducer to be on the membrane. The mechanical scanning of the HIFU probe was used to effectively enlarge the lateral cross section of the HIFU focal spot (approximately 1 mm without scanning). The scanning was done with an HP 3311A function generator (Hewlett Packard), a PA-138 power amplifier (LabWorks, Inc, Costa Mesa, Calif), and an ET-126B electrodynamic shaker (LabWorks, Inc). The frequency and amplitude of the scanning were 15 to 25 Hz and 5 to 10 mm, respectively. Thus, the focus of the transducer was spread over a linear dimension equal to the amplitude of the oscillations. The intensity at the focus was in the range of 2500 to 3000 W/cm 2 for all treatments. Generally, lower intensities were used for the treatment of moderate bleeding, and higher intensities were used for the profuse bleeding.
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Heparin was administered in all the animals at approximately half way through the experiment at a dose of 5,000 or 10,000 units to ensure that the animal was in an anticoagulated state. The blood clotting time was measured at several time points during the normal and anticoagulated states of the animals. the heparinized blood was 2 to 10 times longer than that of the nonheparinized blood.
Control incisions were not performed because of the large amounts of blood loss that were observed. However, in other experiments, seven control punctures (four in femoral arteries and three in femoral veins) were allowed to bleed for 2 minutes freely and for 2 minutes while the HIFU applicator cone was held on the puncture. 2 The punctures continued to bleed at the end of the 4 minutes, with a maximum reduction in the bleeding rate of approximately 50% to about 5 mL/min. This reduction did not meet the definition of major hemostasis with a maximum bleeding rate of 1 mL/min.
All the animals were alive at the end of experiment when they were killed with an overdose of the anesthetic mixture, followed by a 2-mL KCl-saturated solution within 2 minutes. Representative tissue samples were obtained from the HIFU-treated regions and the normal regions of the blood vessels for histologic examination. The tissue samples were fixed in formalin, embedded in paraffin, and stained with hematoxylin and eosin.
RESULTS

Fig 2
shows a representative sequence of photographs that were obtained during the incision and the HIFU treatment of a superficial femoral artery. The scalpel blade is shown over the artery just before the incision was made (Fig 2A) . A jet of blood squirted from the artery after the incision (Fig 2B) . The application of HIFU, with the conical housing, started within 5 seconds of the incision (Fig 2C) . The bleeding was completely arrested at the completion of the HIFU treatment (Fig 2D) . A total of 76 incisions and HIFU treatments were performed in this study. The heart rates and the oxygen saturation levels of the animals were within normal range throughout the experiments.
Sixty-nine of the 76 treatments resulted in the complete cessation of bleeding (complete hemostasis), and seven treatments resulted in a significant reduction of bleeding (major hemostasis) without complete hemostasis (incomplete hemostasis). In all seven treatments with incomplete hemostasis, poor targeting of the HIFU was noted as a result of either massive bleeding and lack of visual cues for probe positioning (four cases) or inaccessibility of the incision site in hard-to-reach regions (three cases). This led to conditions of overexposure of the vessel, at which point further treatment did not seem to reduce the bleeding. In this situation, it appeared that the vessel had become so necrosed that the vessel walls would not fuse to close with further treatment. Therefore, no further treatment was applied, and clamping was used to achieve complete hemostasis. Fig 3 shows four representative examples of HIFU-treated vessels. Complete hemostasis was achieved in all the vessels shown. Fig 3A shows a superficial femoral artery with a slight discoloration of the vessel as a result of the HIFU treatment. The artery was patent after the treatment. A patent vessel was observed after 51 of the 69 treatments (74%) in which complete hemostasis was achieved. Fig 3B shows a superficial femoral artery with severe discoloration and deformation after the HIFU treatment. The treatment site was occluded after the treatment. An occluded site was observed after 18 of 69 treatments (26%). Fig 3C shows a carotid artery with the HIFU-treated region clearly seen on the adventitia. The adventitia was slightly discolored and hardened, predominantly in bands (Fig 3C) that appeared to be in the direction of the mechanical scanning of the HIFU probe. The artery was patent after the treatment. Fig 3D shows a close-up view of a jugular vein. A tight mesh of interlacing strands was observed at the site of the HIFU treatment. The vessel was patent after the treatment.
Occlusion of the vessel at the treatment site (18 of 69 treatments; 26%) occurred in the superficial femoral artery (17 cases) and in the carotid artery (one case). The occlusion appeared to be the result of mechanical deformation of the vessel and not of thrombosis of the blood. In the case of the superficial femoral artery, the occlusions were within 5 cm around the bend of the knee. In all cases, a significant spasm of the artery was observed before incising the vessel, although considerable bleeding, in the form of shooting jets, occurred as a result of incision. The average major and complete hemostasis times for the treatments that resulted in the occlusion of the treatment sites were 22 and 34 seconds, respectively. These values, although slightly higher, were not significantly different from those of the treatments that resulted in patent vessels-15 and 22 seconds, respectively. The P values of the major and complete hemostasis times of patent versus occluded vessels were .13 and .06, respectively. No relationship was found between either the incision length or the HIFU intensity and the occurrence of the occlusion.
Figs 4, 5, and 6 show the results of the histologic analysis on three representative HIFU-treated blood vessels in which complete hemostasis was achieved. Fig 4 shows a superficial femoral artery with an incision (Fig 4A) . A coagulated fibrin network was observed at the incision site, with red blood cells within the network (Fig 4B) . Fig 5 shows another example of a treated superficial femoral artery with an incision site (Fig 5A) . Abundant serous fluid was observed in the coagulated fibrin network (Fig 5B) . Fibrin was observed at the incision site and in the vessel lumen (Fig 5C) . The internal elastic lamina on one edge of the incision appeared to be in contact with the media of the other edge of the incision. Although a precise apposition of the incision edges was not achieved in this case (Fig 5B) , the incision was sealed and complete hemostasis was achieved. Fig 6 shows a carotid artery with an incision (Fig 6A) . Serous fluid was focally observed at the incision site of the vessel, and within a well-developed fibrin network ( Fig  6A,B) . The vessel wall on the opposite side of the lumen showed little or no evidence of HIFU-treatment (Fig 6C) . Possible effects may include: (1) a slight denudation (Fig 6C) , although no platelet aggregation or monocytic attachment (an expected response to denudation) were observed at the denudation site; or (2) the presence of edema fluid (Fig 6C) , although these structures may be fat emboli. All vessels, examined by means of light microscopy, exhibited focal swelling of the wall at the HIFU-treated site, without evidence of irreversible injury.
The mean times of major and complete hemostasis for all vessels were 17 and 25 seconds, respectively. The range, mean, and standard deviation of the major and complete hemostasis times for the blood vessels in which complete hemostasis was achieved are presented in Table II . Complete hemostasis times, as short as 2 seconds, were noted in the jugular vein. Fig 7 shows a plot of the mean and standard deviation of the major and complete hemostasis times for all the HIFU-treated vessels. The hemostasis times of the common femoral artery were the longest (28 and 46 seconds for major and complete hemostasis, respectively), whereas those of the jugular vein were the shortest (7 and 10 seconds for major and complete hemostasis, respectively). Table III shows the results of t test comparisons of all the vessels. A statistically significant difference was observed for the time to control bleeding in the small vessels as compared with the medium-sized vessels (superficial femoral arteries compared with common femoral arteries; Table II ). The hemostasis times of the jugular vein were significantly shorter than the times of all the other vessels (Table II) . A total of 42 incisions and HIFU treatments were performed while the animals were heparinized. No statistically significant differences were found between the major and complete hemostasis times in normal and heparinized conditions. The P values of the major and complete hemostasis times of normal and heparinized conditions were .5 and .3, respectively.
DISCUSSION
We have shown that the application of mechanically scanned HIFU to blood vessel incisions, 2 to 8 mm in length, results in rapid and effective hemostasis. The control of bleeding appears to be due to a combination of tissue coagulation and fibrin deposition. Fibrin may have provided a substrate for soldering at the incision site, and the coagulated adventitia appears to have sealed the breached wall, providing extra support for the fibrin plug. The HIFU effects on the blood vessel walls are thought to be caused by its thermal action. [2] [3] [4] A temperature rise to approximately 70°C has been measured at the focus of HIFU during the treatment of rabbit livers, with HIFU intensities that were similar to those used in the current study. 1 Similar temperatures have been measured during successful vascular coagulation and welding with electrocoagulation 5 and laser therapy. 6 At these temperatures, the alteration of the vessel wall components (collagen, elastin, and smooth muscle) and substrate bonding (collagen-collagen, and collagen-elastin) is expected. 7 In this study, while the use of mechanical-scanning HIFU for the hemostasis of vascular incisions was shown, several interesting observations were made. First, a statistically significant difference was observed for the time to control bleeding of the small vessels as compared with the time to control bleeding of the medium-sized vessels. Although all the tested arteries are of muscular type, the varying content of collagen, elastin, and smooth muscle in these vessels 8 may result in varying effects of HIFU on the vessel. In fact, different temperature ranges are thought to produce different effects of vascular welding. 6 Second, a statistically-significant difference was observed between the hemostasis times of the jugular vein and all the other vessels. The thin wall of the jugular vein seemed to be easily welded with a short application of HIFU. The extensive interlacing strands, observed on the jugular vein after the HIFU treatment, and the low venous pressure may have important implications for the fast hemostasis times. Thirdly, 17 of the 18 occluded sites occurred within 5 cm of the bend of the knee in the superficial femoral artery while the vessel was undergoing a spasm. The structural elasticity and the physiologic state of a blood vessel may have significant implications for the optimal HIFU treatment parameters. In fact, slightly higher hemostasis times, which bordered on statistical significance, were measured for the treatments that resulted in the occlusion of the vessel, as compared with those that resulted in a patent vessel. In general, a careful study of the HIFU parameters, including the frequency, the intensity, the beam pattern, and the corresponding thermal action on vessel wall and its structural components, in varying physiologic conditions, may provide important information for the mechanism of acoustic hemostasis of blood vessels. Finally, no difficulty was experienced in stopping bleeding in animals that had undergone treatment with heparin. The HIFU-induced hemostasis may be independent of normal thrombosis mechanisms.
The thermal effect of our 3.5-MHz HIFU is quite localized. The temperature is maximal at the focus (cross section of 1 mm), with a steep decline of approximately 10°C/mm around the focal spot. 1, 9 This temperature profile can be even steeper if a higher frequency HIFU or a shorter duration excitation is used. 10 Also, because of the short HIFU excitation times, the tissue effects become essentially perfusion independent, providing a method of thermal delivery without significant cooling between exposures. Such focal high temperatures offer a potential tool for the control of bleeding in small places. In the current study, however, the mechanical scanning of HIFU was used to obtain an effective large thermal effect to control the bleeding of large incisions. This method may be useful for the rapid hemostasis of large lacerated surface areas of traumatized livers or spleens.
An important characteristic of HIFU is the radiation pressure, which results in a net bulk flow of liquid known as acoustic streaming. 11 We found this effect to be useful in the control of bleeding. The jet of blood that squirted from the incision generally was stopped as HIFU was applied, and the blood was pushed back into the vessel. We believe that acoustic streaming helped the hemostasis process by: (1) producing a more blood-free environment in which the visualization of the incision site was easier, (2) Table II . Major and complete hemostasis times for high-intensity focused ultrasound treatment of surgically exposed incised blood vessels there was no exiting blood to hold the edges open, and (3) resulting in a more optimal deposition of HIFU energy in the vessel wall because the blood was pushed away from the wound site before it could carry away much heat. The acoustic streaming mechanism may prove to be valuable in the treatment of those types of hemorrhage, such as bleeding ulcers, in which the blood flow causes difficulty in depositing the coagulative energy. 12 Two important studies are necessary for the further advancement of HIFU vascular hemostasis. First, the optimal HIFU parameters (frequency, intensity, and duration) must be determined for specific injuries and blood vessels, particularly with the goal of keeping the vessel patent. The determination of bursting strength and mechanical strength of the vessel after acoustic hemostasis will be an integral part of this study. Second, survival animal studies in which the HIFU treatment sites are monitored for a period after the treatment are essential in further evaluating the efficacy of acoustic hemostasis. Late effects will have to be studied carefully to eliminate the possibility of deleterious effects, such as delayed arterial rupture as a result of possible injury to the vessel wall during the treatment. Such a study would include a careful histologic study of the vessels at the HIFU treatment site and of the surrounding tissue. The above-mentioned studies will have a significant effect on the clinical success of the acoustic hemostasis. Acoustic hemostasis may provide a valuable tool for the surgeon, in both trauma and elective situations. The current blood vessel injury model, in which the injury is relatively minor and the blood vessel wall is still intact, is akin to the situation after an iatrogenic, catheter-related vascular injury. HIFU appears to be highly efficacious in this type of setting, and although it was applied to surgically exposed vessels in this experiment, HIFU has the capability for percutaneous application as well. In fact, in the current study, we used HIFU without the use of a method to control hemorrhage (eg, clamping) to allow the investigation of an extracorporeal application. In most surgical situations, clamping would perhaps provide a fast initial hemostatic mechanism, but HIFU provides the potential of complete hemostasis in the field and in surgical situations where easy access for clamping does not exist. The average treatment time for major and complete hemostasis of 17 and 25 seconds in the current model represents a significant advantage over conventional suturing. Also, HIFU is capable of penetrating tissue to deliver its energy to a deep-seated region with millimeter precision and without affecting the intervening tissue, while other hemostatic techniques, such as laser therapy and electrocautery, are surface techniques and cannot penetrate tissue or blood. The transmission of HIFU through pools of blood during trauma surgery may prove to be an important capability of HIFU. A HIFU-based, acoustic hemostasis method, coupled with an imaging method for localization, targeting, and treatment monitoring, may have extracorporeal, laparoscopic, and endoscopic applications.
